These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients. Tavassoli N, Voisin S, Carrie D, Lapeyre-Mestre M, Galinier M, Montastruc JL, Pathak A. Am J Cardiovasc Drugs; 2010 Mar 15; 10(1):29-35. PubMed ID: 20104932 [Abstract] [Full Text] [Related]
6. Early stent thrombosis in patients undergoing primary coronary stenting for acute myocardial infarction: incidence, a simple risk score, and prognosis. Ergelen M, Uyarel H, Osmonov D, Ayhan E, Akkaya E, Soylu O, Orhan AL, Sayar N, Bozbay M, Turer A, Yildirim E, Yekeler I. Clin Appl Thromb Hemost; 2010 Feb 15; 16(1):33-41. PubMed ID: 19736213 [Abstract] [Full Text] [Related]
8. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study). Tanzilli G, Greco C, Pelliccia F, Pasceri V, Barillà F, Paravati V, Pannitteri G, Gaudio C, Mangieri E. Am J Cardiol; 2009 Nov 15; 104(10):1357-61. PubMed ID: 19892050 [Abstract] [Full Text] [Related]
9. Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results. Chen JL, Gao LJ, Yang YJ, Li JJ, Qiao SB, Xu B, Huang JH, Yao M, Qin XW, Liu HB, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Gao RL. Chin Med J (Engl); 2010 Apr 05; 123(7):778-81. PubMed ID: 20497663 [Abstract] [Full Text] [Related]
10. [Optimal platelet inhibition after coronary stent implantation. Current status]. Silber S, Hoffmeister HM, Bode C. Herz; 2008 Jun 05; 33(4):244-53. PubMed ID: 18581073 [Abstract] [Full Text] [Related]
12. Platelet reactivity in patients with subacute stent thrombosis compared with non-stent-related acute myocardial infarction. Lev EI, Alviar CL, Arikan ME, Dave BP, Granada JF, DeLao T, Tellez A, Maresh K, Kleiman NS. Am Heart J; 2007 Jan 05; 153(1):41.e1-6. PubMed ID: 17174635 [Abstract] [Full Text] [Related]
13. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent. Wang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX, Guo YH, Cheng WJ, Jia de A, Cao Z, Nie B, Ge HL, Yang SW, Yan ZX. Thromb Res; 2009 May 05; 124(1):46-51. PubMed ID: 19041120 [Abstract] [Full Text] [Related]
14. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R. J Am Coll Cardiol; 2009 Sep 01; 54(10):894-902. PubMed ID: 19712798 [Abstract] [Full Text] [Related]
15. Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population. Wiederkehr D, Ogbonnaya A, Casciano R, Makenbaeva D, Mozaffari E, Corbelli J. Curr Med Res Opin; 2009 Sep 01; 25(9):2327-34. PubMed ID: 19635046 [Abstract] [Full Text] [Related]
16. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. Buonamici P, Marcucci R, Migliorini A, Gensini GF, Santini A, Paniccia R, Moschi G, Gori AM, Abbate R, Antoniucci D. J Am Coll Cardiol; 2007 Jun 19; 49(24):2312-7. PubMed ID: 17572245 [Abstract] [Full Text] [Related]